AU782154C - DNA vaccines for pets and sport animals - Google Patents

DNA vaccines for pets and sport animals

Info

Publication number
AU782154C
AU782154C AU55405/00A AU5540500A AU782154C AU 782154 C AU782154 C AU 782154C AU 55405/00 A AU55405/00 A AU 55405/00A AU 5540500 A AU5540500 A AU 5540500A AU 782154 C AU782154 C AU 782154C
Authority
AU
Australia
Prior art keywords
pets
dna vaccines
sport animals
sport
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU55405/00A
Other versions
AU782154B2 (en
AU5540500A (en
Inventor
Jean-Christophe Francis Audonnet
Simona Barzu-Le-Roux
Laurent Jean-Charles Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9907604A external-priority patent/FR2794648B1/en
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of AU5540500A publication Critical patent/AU5540500A/en
Application granted granted Critical
Publication of AU782154B2 publication Critical patent/AU782154B2/en
Assigned to MERIAL LTD reassignment MERIAL LTD Amend patent request/document other than specification (104) Assignors: MERIAL
Publication of AU782154C publication Critical patent/AU782154C/en
Assigned to MERIAL, INC. reassignment MERIAL, INC. Alteration of Name(s) in Register under S187 Assignors: MERIAL LTD
Assigned to Boehringer Ingelheim Animal Health USA Inc. reassignment Boehringer Ingelheim Animal Health USA Inc. Request for Assignment Assignors: MERIAL, INC.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU55405/00A 1999-06-10 2000-06-08 DNA vaccines for pets and sport animals Expired AU782154C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9907604A FR2794648B1 (en) 1999-06-10 1999-06-10 DNA VACCINES FOR PETS AND SPORTS
FR9907604 1999-06-10
US14449099P 1999-07-19 1999-07-19
US60/144490 1999-07-19
PCT/FR2000/001592 WO2000077043A2 (en) 1999-06-10 2000-06-08 Dna vaccines for pets and sport animals

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2005202233A Division AU2005202233B2 (en) 1999-06-10 2005-05-23 DNA vaccines for pets and sport animals

Publications (3)

Publication Number Publication Date
AU5540500A AU5540500A (en) 2001-01-02
AU782154B2 AU782154B2 (en) 2005-07-07
AU782154C true AU782154C (en) 2006-02-09

Family

ID=26234993

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55405/00A Expired AU782154C (en) 1999-06-10 2000-06-08 DNA vaccines for pets and sport animals

Country Status (11)

Country Link
EP (1) EP1185662B1 (en)
JP (1) JP2003502345A (en)
KR (1) KR100768114B1 (en)
AR (1) AR024334A1 (en)
AU (1) AU782154C (en)
BR (1) BR0011732B1 (en)
CA (1) CA2375320C (en)
CZ (1) CZ20014392A3 (en)
NZ (1) NZ515993A (en)
PL (1) PL210451B1 (en)
WO (1) WO2000077043A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804028B1 (en) * 2000-01-21 2004-06-04 Merial Sas IMPROVED DNA VACCINES FOR PENSION ANIMALS
FR2823222B1 (en) 2001-04-06 2004-02-06 Merial Sas VACCINE AGAINST NILE FEVER VIRUS
FR2825280B1 (en) * 2001-06-01 2005-04-15 Merial Sas VACCINATION AGAINST THE FELINE IMMUNODEFICIENCY VIRUS
US20050214316A1 (en) 2003-11-13 2005-09-29 Brown Thomas P Methods of characterizing infectious bursal disease virus
DE602006013117D1 (en) 2005-04-25 2010-05-06 Merial Ltd NIPAH VIRUS VACCINES
ES2373238T3 (en) * 2005-09-16 2012-02-01 Merial Ltd. STABILIZERS FOR LIOFILIZED VACCINES.
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
US8877206B2 (en) 2007-03-22 2014-11-04 Pds Biotechnology Corporation Stimulation of an immune response by cationic lipids
CN110075113A (en) 2008-04-17 2019-08-02 Pds生物科技公司 Immune response is stimulated by the enantiomer of cation lipid
ES2732815T3 (en) 2009-05-22 2019-11-26 Genocea Biosciences Inc Vaccines against herpes simplex virus type 2: compositions and methods to elicit an immune response
US20130197612A1 (en) * 2010-02-26 2013-08-01 Jack W. Lasersohn Electromagnetic Radiation Therapy
CA2856697A1 (en) 2010-11-24 2012-06-07 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
JP6199878B2 (en) 2011-11-23 2017-09-20 ジェノセア バイオサイエンシーズ， インコーポレイテッド Nucleic acid vaccine against herpes simplex virus type 2: Compositions and methods for inducing an immune response
KR20150058139A (en) * 2012-06-15 2015-05-28 피디에스 바이오테크놀러지 코퍼레이션 Cationic lipid vaccine compositions and methods of use
EP4091630A1 (en) 2012-09-21 2022-11-23 PDS Biotechnology Corporation Vaccines comprising r-dotap
CN104164409A (en) * 2014-07-18 2014-11-26 中国人民解放军军事医学科学院军事兽医研究所 Recombinant canine distemper virus (rCDV) containing canine GMCSF (granulocyte macrophage colony stimulating factor) gene and preparation method thereof
CN104958283A (en) * 2015-06-02 2015-10-07 北京盛大康成医疗技术有限公司 Alkalescence skin mucosa cleaning and disinfecting composition and preparing method and application thereof
AU2016354590B2 (en) 2015-11-13 2023-11-23 Pds Biotechnology Corporation Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
KR101694676B1 (en) 2015-12-10 2017-01-10 우진 비앤지 주식회사 Streptococcus equi strain and the vaccine composition comprising the same
JP2019537555A (en) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド Methods and compositions for treating herpes
BR112021013241A2 (en) 2019-01-04 2021-09-14 Boehringer Ingelheim Animal Health USA Inc. ATTENUATED STRAINS OF BORDETELLA BRONCHISEPTICA, ORAL VACCINES CONTAINING THE ATTENUATED STRAINS AND METHODS OF PREPARATION AND USE THEREOF

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1131200A (en) * 1998-10-23 2000-05-15 Heska Corporation Cationic lipid-mediated enhancement of nucleic acid immunization of cats

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338683A (en) * 1981-12-24 1994-08-16 Health Research Incorporated Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
EP1624068A1 (en) * 1993-06-01 2006-02-08 Life Technologies Inc. Genetic immunization with cationic lipids
ES2293639T3 (en) * 1994-03-30 2008-03-16 Connaught Technology Corporation SEQUENCES OF NUCLEOTIDES AND AMINO ACIDS OF THE VIRUS GB, GC AND GD OF THE CANINE HERPES AND ITS USES.
EP0826063A1 (en) * 1995-04-25 1998-03-04 Vical Incorporated Single-vial formulations of dna/lipid complexes
ES2109189B1 (en) * 1996-03-14 1998-05-16 Iberica Cyanamid VECTORS BASED ON RECOMBINANT DEFECTIVE VIRAL GENOMES AND THEIR USE IN THE FORMULATION OF VACCINES.
WO1997041236A1 (en) * 1996-04-29 1997-11-06 Andreas Zurbriggen Polynucleotide vaccine against canine distemper
FR2751223B1 (en) * 1996-07-19 1998-12-04 Rhone Merieux FELIN POLYNUCLEOTIDE VACCINE FORMULA
FR2751227B1 (en) * 1996-07-19 1998-11-27 Rhone Merieux POLYNUCLEOTIDE VACCINE FORMULA AGAINST CANINE CONDITIONS, ESPECIALLY RESPIRATORY AND DIGESTIVE CONDITIONS
FR2751226B1 (en) * 1996-07-19 1998-11-27 Rhone Merieux POLYNUCLEOTIDE VACCINE FORMULA AGAINST HORSE PATHOLOGIES
WO1998040499A1 (en) * 1997-03-10 1998-09-17 Heather Lynn Davis Gene delivery to mucosal epithelium for immunization or therapeutic purposes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1131200A (en) * 1998-10-23 2000-05-15 Heska Corporation Cationic lipid-mediated enhancement of nucleic acid immunization of cats

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KLAVINSKIS ET AL. THE JOURNAL OF IMMU. (1999) 162(1) 254-262 *
OKADA ET AL. THE JOURNAL OF IMMUN. (1997) 159 3638-3647 *

Also Published As

Publication number Publication date
BR0011732A (en) 2002-03-05
KR100768114B1 (en) 2007-10-17
WO2000077043A3 (en) 2001-07-19
WO2000077043A2 (en) 2000-12-21
EP1185662B1 (en) 2011-03-02
CA2375320A1 (en) 2000-12-21
AU782154B2 (en) 2005-07-07
AU5540500A (en) 2001-01-02
EP1185662A2 (en) 2002-03-13
AR024334A1 (en) 2002-10-02
KR20020012271A (en) 2002-02-15
CZ20014392A3 (en) 2002-06-12
BR0011732B1 (en) 2014-02-04
NZ515993A (en) 2004-04-30
JP2003502345A (en) 2003-01-21
PL352212A1 (en) 2003-08-11
PL210451B1 (en) 2012-01-31
CA2375320C (en) 2013-02-19

Similar Documents

Publication Publication Date Title
AU782154C (en) DNA vaccines for pets and sport animals
AU2362300A (en) Animal litter
AU1828897A (en) Animal leash
AU2002243489A1 (en) Automatic cat grooming, feeding and litterbox apparatus
AU3374900A (en) Animal grooming apparatus
HUP0600236A2 (en) Litter for cats and small animals
AU4830200A (en) Animal walking and training collar
AUPQ296999A0 (en) Animal carcase analysis
AU2364300A (en) Animal litter container
AU2002364907A1 (en) Adjustable cat litter scoop
AU5329300A (en) Feline calicivirus isolated from cat urine and vaccines thereof
IL137845A0 (en) An implement for feeding and/or watering animals
GB9912905D0 (en) An animal over-garment
GB9902026D0 (en) Animal litter arrangements
GB0001701D0 (en) An animal feed
GB2356124B (en) Animal feed
AU1415501A (en) Novel polypeptide, novel dna, novel anitbody and novel transgenic animal
AU6601200A (en) Method and system for electronically examining animals such as cows
AU2001240669A1 (en) Method and use for biologically marking animals and animal products
AU3171500A (en) Litter for small pets, comprising ground dried-fruit shells
EP1145630A2 (en) Cattle grooming device
AUPQ371799A0 (en) Animal husbandry
AUPQ454499A0 (en) Animal husbandry system
AU2001285199A1 (en) Methods for de-hairing animals and animal hides
AU2002229446A1 (en) Hog farming process and barn

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.

Free format text: FORMER OWNER(S): MERIAL, INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired